Cheng Xin Technology Development chengxin.com.tw

Cheng Xin Technology Development - Investments & Acquisitions

Show Real Data Cheng Xin Technology Development Investments
See all Recent Investments
Date Company Round Amount Co-investors
2011-04-11Cellerant TherapeuticsUnattributed VC - III$2.02MBecton Dickinson and Company - Respiratory Solutions Business, Biomedical Advanced Research and Development Authority, Camelot Venture Group, Eminent Venture Capital, MPM Capital, and Sagamore BioVentures
2010-06-07Cellerant TherapeuticsUnattributed VC - II$4.53MBecton Dickinson and Company - Respiratory Solutions Business, Biomedical Advanced Research and Development Authority, Camelot Venture Group, Eminent Venture Capital, MPM Capital, and Sagamore BioVentures
2005-07-18Altea TherapeuticsSeries C$30MAperture Venture Partners, Domain Associates, KBC Private Equity, Quilvest Private Equity, Rockport Venture Partners, Venrock, and vSpring Capital
2004-04-13AGY TherapeuticsSeries C$40.3MAlta Partners, Bear Stearns, China Development Industrial Bank, Forward Ventures, GE Capital, Gimv, HBM BioVentures, HBM Partners, JAFCO Life Science Investment, LODH Private Equity Partners, Lotus Biosciences, MIC Capital, NIF SMBC Ventures, and Novartis Venture Funds
2000-03-23VermillionUnattributed VC$28.57MAmadeus Capital Partners, AP Anlage und Privatbank AG, Atlas Venture, Central Investment Holding, China Development Industrial Bank, Clariden Leu, Essex Investment Management Company, Falcon Technology Venture Partners, First Bio Venture Capital, Forward Ventures, Grand Capital International, HLM Venture Partners, Hoover and Associates, Lumira Capital, MDS, Morgan Stanley, OrbiMed Advisors, Pentech Financial Services, SR One, Stanford Research Systems, and Winchester Global Trust Company Ltd
See all 7 investments